Home »
PRN Pharmacal announces a new annual Veterinary Technician Awards Program to recognize credentialed vet techs for their dedication, compassion, and clinical expertise. Winners receive $500 awards to support education and career growth.
First-in-class oral management option for hypertrophic cardiomyopathy (HCM) earns FDA conditional approval, changing the landscape of feline medicine
New dental device provides an advanced, yet simple, option for the filling and augmentation of bony and periodontal defects in dogs.
The strategic combination brings leading-edge product Felycin®-CA1 (Sirolimus Delayed-Release Tablets) and innovative pipeline together with PRN® Pharmacal leading expertise in commercializing new therapies for chronic pet health conditions Shawnee, Kansas, May 5,...
PRN® Pharmacal is marking National Epilepsy Awareness Month by offering one free neurology consult with Web Vet Seizure Specialists for every two bottles of KBroVet®-CA1 180 count bottles purchased during November and December.
CoproBan® Soft Chews are now available in a 40-count jar featuring updated consumer-friendly packaging and improved pet acceptance, helping make canine coprophagia (the eating of feces) easier to control.
The U.S. Food and Drug Administration (FDA) has approved Firocoxib Tablets for Dogs. To be marketed under the brand name Sē•Qual™, Firocoxib Chewable Tablets for Dogs joins Firocoxib Tablets for Horses as the second generic nonsteroidal anti-inflammatory drug (NSAID)...
Pegasus Laboratories dba PRN Pharmacal will transition from chicken-based protein flavoring in its prescription product, KBroVet®-CA1 (potassium bromide chewable tablets) to a new French vanilla flavor. The FDA-approved change comes in response to concerns regarding...
PRN® Pharmacal has enhanced the UniversityPRN.com training module site. Focusing on a better partnership between customer service and distribution sales representatives, the site currently features six product-specific training modules, each ranging from three to five...
The U.S. Food and Drug Administration (FDA) has approved Firocoxib Tablets for Horses. To be marketed under the brand name Sē•Qual™, Firocoxib Tablets for Horses will be the first generic nonsteroidal anti-inflammatory drug (NSAID) used to treat pain and inflammation...